| Metric | Value (₹ Cr) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 18.96 | 1.8% | 16.8% |
| Total Income | 19.51 | 1.8% | 17.1% |
| Expenditure | 15.88 | 5.1% | 18.1% |
| PBT | 3.63 | 48.9% | 12.9% |
| Net Profit | 2.62 | 43.4% | 8.8% |
| OPM | 17.55% | 6.18pp | 1.98pp |
| NPM | 13.42% | 3.89pp | 1.03pp |
| EPS | 4.55 | 43.5% | 8.8% |
BDH Industries Ltd Reports Q2 and H1 Results for FY 2025-26 with 8.33% YoY Growth in Revenue
12 Nov 2025 · 12 Nov 2025, 06:56 pm
Summary
BDH Industries Ltd, a company with operations in Pharmaceuticals and Renewable Energy, has reported its Q2 and H1 results for the financial year 2025-26. The company has reported an 8.33% YoY growth in revenue. The Standalone Unaudited Financial Results were reviewed by the Audit Committee and approved by the Board of Directors.
Key Highlights
- 1
Q2 and H1 results for FY 2025-26 reported
- 2
8.33% YoY growth in revenue
- 3
Operations in Pharmaceuticals and Renewable Energy
- 4
Standalone Unaudited Financial Results reviewed by the Audit Committee
Management Comments
Not Provided
The above Standalone Unaudited Financial Results were reviewed by the Audit Committee and thereafter approved and taken on record by the Board of Directors at their meeting held on 12th November, 2025. The Statutory Auditors of the Company have expressed an unmodified review conclusion thereon.
Informational and educational content only. Not investment advice.